Approximately 90% of women of childbearing age use some form of contraception. Despite this, nearly 50% of pregnancies in the United States are unintentional. Of these, 43% result in live births, 13% in miscarriages, and 44% end in elective abortion
Theoretical efficacy rate refers to the efficacy of contraception when used exactly as instructed. Actual efficacy rate refers to efficacy when used in real life, assuming variations in the consistency of usage
Requires instruction on the physiology of menstruation and conception and on methods of determining ovulation
Requires the woman to have regular, predictable menstrual cycles
Ovulation assessment methods may include ovulation prediction kits, basal body temperature measurements, menstrual cycle tracking, cervical mucus evaluation, and/or documentation of any premenstrual or ovulatory symptoms
Continuation of nursing has long been a widespread method of contraception. After delivery, the restoration of ovulation is delayed because of a nursing-induced hypothalamic suppression of ovulation
50% of lactating mothers will begin to ovulate between 6 and 12 months after delivery, even while breastfeeding. Return of ovulation occurs before the return of menstruation
A pouch made of polyurethane that has a flexible ring at each end, with one ring fitting into the depth of the vagina and the other staying outside the vagina near the introitus
A dome-shaped latex rubber sheet stretched over a thin coiled rim, with spermicidal jelly placed on the rim and on either side, and placed into the vagina to cover the cervix
When properly and consistently used with condoms, spermicides can have an effectiveness rate as high as 95%. However, in actual usage, the efficacy of spermicides when used alone is only 70% to 75%
Spermicides do not confer any protection against sexually transmitted infections (STIs) and may make the user more susceptible to STIs including HIV by causing vaginal irritation
Spermicides should not be used by women with HIV or at high risk of contracting HIV, especially in developing nations where contraception and STI prevention are paramount
In the 1960s and 1970s, IUDs became extremely popular in the United States, but legal ramifications stemming from pelvic infections associated with the Dalkon shield resulted in consumer fear and limited availability of all IUDs
Currently, only two IUDs are available in the United States: the intrauterine Copper-T IUD (TCu-380A or ParaGard) and the levonorgestrel intrauterine system (LNG-20 or Mirena)
Despite previous fears, there are nearly 100 million IUD users globally, making the IUD the most widely used method of reversible contraception in the world